EE267 Budget Impact Analysis of Introducing Fruquintinib for the Treatment of Previously Treated Metastatic Colorectal Cancer in the United States From the Payer Perspective
Abstract
Authors
LG Hernandez V Paly S Li P Khanduri AA Asfaw D Zou